HGC Investment Management Inc. - PHOENIX BIOTECH ACQUISITION ownership

Back to all holdings Add to watchlist

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K105. A total of 47 filers reported holding PHOENIX BIOTECH ACQUISITION in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Links
Filings
Quarter-by-quarter ownership
HGC Investment Management Inc. ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q4 2022$10,180
-99.8%
1,000,000
+100.0%
0.44%
+30.5%
Q3 2022$5,045,000
-49.6%
500,000
-50.0%
0.34%
+11.4%
Q2 2022$10,013,000
+100.1%
1,000,000
+100.0%
0.31%
+2.3%
Q1 2022$5,003,000–500,000–0.30%–
 Download
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q4 2022
NameSharesValueWeighting ↓
Yakira Capital Management, Inc. 108,103$1,177,7820.32%
METEORA CAPITAL, LLC 169,897$1,841,6830.31%
Mint Tower Capital Management B.V. 141,089$1,5320.24%
BERKLEY W R CORP 47,199$512,5810.03%
Shaolin Capital Management LLC 50,000$5430.02%
CLEAR STREET LLC 73,364$7970.01%
Walleye Capital LLC 47,936$520,5850.00%
Walleye Trading LLC 26,964$292,8290.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 10,588$114,9850.00%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders